Skip to main content
Log in

Priapism in Fabry's disease during testosterone treatment

  • Eilige Kurzmitteilung
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Desnick RJ, Sweeley CC (1983) Fabry's disease: α-Galactosidase A deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. New York: McGraw-Hill, pp 906–944

    Google Scholar 

  2. Funderburk SJ, Philippart M, Dale G, Cederbaum SD, Vyden JK (1974) Priapism after phenoxybenzamine in a patient with Fabry's disease. N Engl J Med 290:630–631

    Google Scholar 

  3. Wilson SK, Klionsky BL, Rhamy RK (1973) A new etiology of priapism: Fabry's disease. J Urol 109:646–648

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endres, W., Shin, Y.S., Rieth, M. et al. Priapism in Fabry's disease during testosterone treatment. Klin Wochenschr 65, 925 (1987). https://doi.org/10.1007/BF01745504

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01745504

Key words

Navigation